ArticleDermatology and therapy2026

Real-World Effectiveness and Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: A 52-Week Retrospective Italian Study Focusing on Head and Neck Involvement.

Luigi Gargiulo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.